Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Expanding the mutational spectrum of ReNU syndrome: insights into 5’ Stem-loop variants

Abstract

A narrow spectrum of heterozygous variants in RNU4-2, encoding the small nuclear RNA (snRNA) U4, underlies ReNU syndrome, a neurodevelopmental disorder (NDD) characterized by moderate to severe developmental delay (DD), intellectual disability (ID), a distinctive facial gestalt, and multisystem involvement. Pathogenic variants have primarily been reported within an 18-nt critical region contributing to stabilizing the U4/U6 snRNA duplex and proper spliceosome assembly. By combining whole genome sequencing reanalysis and targeted direct sequencing in 190 molecularly unexplained NDD cases, we report on five affected individuals carrying pathogenic/putative pathogenic RNU4-2 variants (2.6%). Three individuals harbored the recurrent pathogenic n.64_65insT variant, while two were heterozygous for private/rare maternally inherited variants (n.30 A > T and n.43_44insT) within the 5’ Stem-loop region. Deep clinical phenotyping confirmed a homogeneous constellation of features in all individuals, with global DD, ID, brain malformations, and a recognizable facial gestalt representing core findings. Based on structural homology models and available cryo-EM data, n.30 A > T and n.43_44insT were predicted to disrupt key intra- and inter-molecular interactions critical for spliceosome function. Our findings expand the mutational spectrum of ReNU syndrome, and confirm the 5’ Stem-loop as a second mutational hotspot in RNU4-2. We propose that a more complex genetics likely underlies the inheritance of a subset of disease-causing RNU4-2 variants from an apparently unaffected parent. We anticipate a relatively high proportion of pathogenic RNU4-2 variants among individuals with unclassified NDD despite extensive genomic testing, and propose a set of facial gestalt core features as a clinical screening tool to prioritize patients for RNU4-2 analysis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Two-dimensional predicted structure of U4/U6 snRNAs duplex.
Fig. 2: Clinical and instrumental findings of the five individuals with heterozygous RNU4-2 variants.
Fig. 3: Superposition of 3D models of the U4 snRNA 5’ Stem-loop (ribonucleotides 18-54) generated by AlphaFold 3.
Fig. 4: Intramolecular and intermolecular interactions of the A30, G43, A44 ribonucleotides of the 5’ Stem-loop in the U4/U6.U5 tri-snRNP complex generated using UCSF Chimera.

Similar content being viewed by others

Data availability

The sequencing data that support the findings of this work are available on request from the corresponding author. The data are not publicly available due to due to privacy/ethical restrictions. The new variants identified in this work and their clinical association have been submitted to ClinVar (n.30 A > T, VCV003390371.1; n.43_44insT, VCV003390370.1).

References

  1. Alvarez-Mora MI, Sanchez A, Rodriguez-Revenga L, Corominas J, Rabionet R, Puig S, et al. Diagnostic yield of next-generation sequencing in 87 families with neurodevelopmental disorders. Orphanet J Rare Dis. 2022;17:60.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Wright CF, Campbell P, Eberhardt RY, Aitken S, Perrett D, Brent S, et al. Genomic diagnosis of rare pediatric disease in the United Kingdom and Ireland. N. Engl J Med. 2023;388:1559–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Chen Y, Dawes R, Kim HC, Ljungdahl A, Stenton SL, Walker S, et al. De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndrome. Nature 2024;632:832–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Greene D, Thys C, Berry IR, Jarvis J, Ortibus E, Mumford AD, et al. Mutations in the U4 snRNA gene RNU4-2 cause one of the most prevalent monogenic neurodevelopmental disorders. Nat Med. 2024;30:2165–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Barbour K, Bainbridge MN, Wigby K, Besterman AD, Chuang NA, Tobin LE, et al. The face and features of RNU4-2: a new, common, recognizable, yet hidden neurodevelopmental disorder. Pediatr Neurol. 2024;161:188–93.

    Article  PubMed  Google Scholar 

  6. Burns VF, Radford EJ. ReNU syndrome - a newly discovered prevalent neurodevelopmental disorder. Trends Genet. 2024;40:914–6.

    Article  CAS  PubMed  Google Scholar 

  7. Wan R, Yan C, Bai R, Wang L, Huang M, Wong CC, et al. The 3.8A structure of the U4/U6.U5 tri-snRNP: Insights into spliceosome assembly and catalysis. Science (1979). 2016;351:466–75.

    CAS  Google Scholar 

  8. Nguyen THD, Galej WP, Bai X-C, Oubridge C, Newman AJ, Scheres SHW, et al. Cryo-EM structure of the yeast U4/U6.U5 tri-snRNP at 3.7 Å resolution. Nature 2016;530:298–302.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Nava C, Cogne B, Santini A, Leitão E, Lecoquierre F, Chen Y, et al. Dominant variants in major spliceosome U4 and U5 small nuclear RNA genes cause neurodevelopmental disorders through splicing disruption. medRxiv. 2024;:2024.10.07.24314689.

  10. Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics. 2013;43:11 10 1–11 10 33.

    PubMed  Google Scholar 

  11. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43:491–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Charenton C, Wilkinson ME, Nagai K. Mechanism of 5’ splice site transfer for human spliceosome activation. Science (1979). 2019;364:362–7.

    CAS  Google Scholar 

  13. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605–12.

    Article  CAS  PubMed  Google Scholar 

  14. Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630:493–500.

  15. Rosenblum J, Beysen D, Jansen AC, De Rademaeker M, Reyniers E, Janssens K, et al. RNU4-2-related neurodevelopmental disorder is associated with a recognisable facial gestalt. Clin Genet. 2025;107:104–12.

    Article  CAS  PubMed  Google Scholar 

  16. Schot R, Ferraro F, Geeven G, Diderich KEM, Barakat TS. Re-analysis of whole genome sequencing ends a diagnostic odyssey: Case report of an RNU4-2 related neurodevelopmental disorder. Clin Genet. 2024;106:512–7.

    Article  CAS  PubMed  Google Scholar 

  17. Ropers HH, Wienker T. Penetrance of pathogenic mutations in haploinsufficient genes for intellectual disability and related disorders. Eur J Med Genet. 2015;58:715–8.

    Article  PubMed  Google Scholar 

  18. Fernandes IR, Cruz ACP, Ferrasa A, Phan D, Herai RH, Muotri AR. Genetic variations on SETD5 underlying autistic conditions. Dev Neurobiol. 2018;78:500–18.

    Article  CAS  PubMed  Google Scholar 

  19. Powis Z, Farwell Hagman KD, Mroske C, McWalter K, Cohen JS, Colombo R, et al. Expansion and further delineation of the SETD5 phenotype leading to global developmental delay, variable dysmorphic features, and reduced penetrance. Clin Genet. 2018;93:752–761.

    Article  CAS  PubMed  Google Scholar 

  20. Amllal N, Elalaoui SC, Zerkaoui M, Chiguer A, Afif L, Izgua AT, et al. Identification of two novel ANKRD11 mutations: highlighting incomplete penetrance in KBG syndrome. Ann Lab Med. 2024;44:110–117.

    Article  CAS  PubMed  Google Scholar 

  21. Beunders G, Voorhoeve E, Golzio C, Pardo LM, Rosenfeld JA, Talkowski ME, et al. Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminus. Am J Hum Genet. 2013;92:210–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ansari M, Faour KNW, Shimamura A, Grimes G, Kao EM, Denhoff ER, et al. Heterozygous loss-of-function SMC3 variants are associated with variable growth and developmental features. HGG Adv. 2024;5:100273.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Greene D, De Wispelaere K, Lees J, Katrinecz A, Pascoal S, Hales E, et al. Mutations in the U2 snRNA gene RNU2-2P cause a severe neurodevelopmental disorder with prominent epilepsy. medRxiv. 2024:2024.09.03.24312863.

  24. Quinodoz M, Rodenburg K, Cvackova Z, Kaminska K, de Bruijn SE, Iglesias-Romero AB, et al. De novo and inherited dominant variants in U4 and U6 snRNAs cause retinitis pigmentosa. medRxiv. 2025:2025.01.06.24317169.

  25. van Rooij J, Arp P, Broer L, Verlouw J, van Rooij F, Kraaij R, et al. Reduced penetrance of pathogenic ACMG variants in a deeply phenotyped cohort study and evaluation of ClinVar classification over time. Genet Med. 2020;22:1812–1820.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kingdom R, Wright CF. Incomplete penetrance and variable expressivity: from clinical studies to population cohorts. Front Genet. 2022;13:920390.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Cooper DN, Krawczak M, Polychronakos C, Tyler-Smith C, Kehrer-Sawatzki H. Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum Genet. 2013;132:1077–130.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Stewart O, Gruber C, Randolph HE, et al. Monoallelic expression can govern penetrance of inborn errors of immunity. Nature 2025;637:1186–1197.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We wish to thank the families who participated in this study, and Prof. A Pichiecchio for the brain MRI data (Subjects 4 and 5). This work was performed in the frame of the collaborative research activity of the European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA (EU Framework Partnership Agreement ID: 3HP-HP-FPA ERN-01-2016/739516).

Funding

This work was supported, in part, by grants from the Italian Ministry of Health (Current Research Funds, to EMV and MT; RCR-2022-23682289 to FMS, EMV, GZ and MT; RF-2021-12374963, to MT).

Author information

Authors and Affiliations

Authors

Contributions

AB and MT conceived the work. AB, CMa, LC and MT wrote the manuscript. AB, CMa, LC, CC, AC, VC, and MF performed the genomic analyses, and analyzed and validated the genomic data. MC performed the structural analyses. MCB, SGC, ADF, LG, CL, CMe, RO, FP, DP, FSa, FSi, EMV and GZ collected the clinical data. MN, MP, and FCR performed the clinical data analyses. All coauthors provided critical feedback on the manuscript.

Corresponding author

Correspondence to Marco Tartaglia.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

The study was approved by the local Institutional Ethical Committee (ref. 1702_OPBG_2018 and 2072_OPBG_2020). Clinical data, pictures, and DNA samples were collected, used, and stored after signed informed consents from the participating subjects/families were secured. Written informed consents were obtained for publication of individual pictures

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bruselles, A., Mancini, C., Chiriatti, L. et al. Expanding the mutational spectrum of ReNU syndrome: insights into 5’ Stem-loop variants. Eur J Hum Genet 33, 432–440 (2025). https://doi.org/10.1038/s41431-025-01820-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41431-025-01820-1

Search

Quick links